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Abstract
Background: Several molecular changes occur following axotomy, such as gene up-regulation and down-regulation. 
In our previous study using Affymetrix arrays, it was found that after the axotomy of sciatic nerve, there were many 
novel genes with significant expression changes. Among them, neuronatin (Nnat) was the one which expression was 
significantly up-regulated. Nnat was identified as a gene selectively expressed in neonatal brains and markedly 
reduced in adult brains. The present study investigated whether the expression of Nnat correlates with symptoms of 
neuropathic pain in adult rats with transected sciatic nerve.
Methods: Western blotting, immunohistochemistry, and the Randall and Selitto test were used to study the protein 
content, and subcellular localization of Nnat in correlation with pain-related animal behavior.
Results: It was found that after nerve injury, the expression of Nnat was increased in total protein extracts. 
Unmyelinated C-fiber and thinly myelinated A-δ fiber in adult dorsal root ganglions (DRGs) were the principal sub-
population of primary afferent neurons with distributed Nnat. The increased expression of Nnat and its subcellular 
localization were related to mechanical hyperalgesia.
Conclusions: The results indicated that there was significant correlation between mechanical hyperalgesia in axotomy 
of sciatic nerve and the increased expression of Nnat in C-fiber and A-δ fiber of adult DRG neurons.
Background
Neuropathic pain in humans can be caused by peripheral
nerve injury resulting in spontaneous pain, thermal and
mechanical hyperalgesia and allodynia. Such clinical
symptoms and signs frequently affect the subject's quality
of life and functional status. It may even lead to psycho-
social incapacitation.
Neuropathic pain still remains refractory to treatment,
as available clinical therapies are often inadequate. In
order to better understand the underlying molecular
mechanisms of neuropathic pain and to develop new
effective therapies, numerous research studies have
focused on molecular changes after peripheral nerve
injury that may participate in generation and mainte-
nance of neuropathic pain. Our previous study using
Affymetrix arrays (Additional file 1) identified many
novel genes with significant expression changes, and one
of them was neuronatin (Nnat).
Nnat was initially recognized as a gene selectively
expressed in neonatal brains and markedly reduced in
brains from young and aged adults. It was therefore
thought to be involved mainly in neuronal cell growth
and differentiation during brain development [1]. Nnat
was also identified as an imprinting gene, and has two
alternative mRNA spliced forms: neuronatin-α (Nnat-α)
and neuronatin-β (Nnat-β). Both have the same open
reading frame with Nnat-α encoding 81 aa and Nnat-β 54
aa. It has been suggested that Nnat-α has three exons and
Nnat-β contains only the first and third exons. Nnat-β
therefore appears to be derived from the α-form with the
middle exon spliced out [2].
To date, no study has examined the altered expression
of Nnat in dorsal root ganglion (DRG) after axotomy of
sciatic nerve in adult rats. This research study was there-
fore conducted using Western blot, immunohistochemi-
cal studies, and animal behavior test to establish the
p o s s i b l e  r o l e  o f  N n a t  i n  D R G  a f t e r  p e r i p h e r a l  n e r v e
injury.
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Methods
The experimental protocol was reviewed and approved
by the Institutional Animal Care and Use Committee of
the Chang Gung Memorial Hospital. The male Sprague-
Dawley (S-D) rats were housed in solid floored cages with
a deep layer of sawdust and cages were changed daily. A
12:12 h light-dark cycle was used and animals were
allowed free access to sufficient food and water. A periph-
eral nerve axotomized model was used to generate neuro-
pathic pain [3]. Approximately 8 weeks old male S-D rats
(n  = 36) weighing 270-300 gram received a unilateral
(left) sciatic nerve transection under deep anesthesia with
inhaled anesthetic and oxygen (2% Isoflurane with 2 L/
min oxygen flow). The left sciatic nerve was exposed via a
lateral approach. Proximal to the sciatic trifurcation, the
nerve was freed of adhering connective tissue along 7-10
mm. One third to one half of the nerve was ligated tightly
with 4-O chromic gut suture then the nerve was
transected distal to the ligation. The incision was then
closed in layers under aseptic conditions. The control
(sham-operation; n = 9) rats underwent the same surgical
procedure as described above but without nerve ligation
and transaction. Finally, the animals were sacrificed at the
following time points: post-operation day 1, 3, 5, and 7 (n
= 9 for each group). Ipsilateral (left) injured L4-L5 DRGs
were taken as specimens for further molecular and bio-
chemical assessment.
The rat paw pressure test [4] was used for determina-
tion of hyperalgesia in male S-D rats of approximately 8
weeks of age (n = 10 for control and each time group). An
Ugo-Basile pressure apparatus was used to assess pres-
sure pain thresholds prior to sciatic nerve transection and
again at different times. Testing was blind in regard to
group designation. Brief, increasing force (16 g/s) was
applied to the right hind paw. The force needed to induce
paw withdrawal was recorded as the pain threshold. T o
reduce stress, the rats were familiarized with the testing
procedure the day before the experiment. To minimize
damage to the paw, a maximum force of 160 g (i.e. cut-
off) was established for the test applied after the pharma-
cological treatments.
For the Western blot study, left L4-L5 DRGs from 3 rats
of control and experimental group (post-axotomy day 1,
3, 5, and 7) were pooled and homogenized in lysis buffer.
Protease inhibitor (Sigma) was added to prevent protein
degradation. The protein content of supernatant was
determined by BCA Protein Assay (Pierce, USA). Total
Nnat (Nnat-α and Nnat-β) and glyceraldehydes 3-phos-
phate dehydrogenase (GAPDH) was electrophoretically
separated on 10% SDS-polyacrylamide gel at 120 volts for
90 min. Proteins were then transferred to the polyvi-
nylidene difluoride (PVDF) membrane (Immobilon-P,
Millipore, 0.45 μM pore size) in a transfer buffer at 100
volts for 60 min at 4°C. The membrane was blocked over-
night at 4°C with 5% non-fat dry milk in Tris-buffered
saline Tween-20 (TBST: 20 mM Tris-HCl, 137 mM NaCl,
0.1% Tween-20, pH 7.5). The PVDF membrane was incu-
bate with rabbit polyclonal antibody specific for total
Nnat (Nnat-α and Nnat-β) (1:300; Santa Cruz, USA) and
mouse monoclonal antibody specific for GAPDH (1:7500;
Santa Cruz, USA) for 16-18 hours at 4°C. Blots were
washed with TBST first and then incubated with goat
anti-rabbit IgG and goat anti-mouse IgG horseradish per-
oxidase-conjugated secondary antibody (1:10000 for goat
anti-rabbit IgG and 1:5000 for goat anti-mouse IgG; Santa
Cruz, USA) for 1 hour at room temperature. Color
molecular weight standard markers were run on each gel.
Western blot results were quantified by densitometry.
For immunohistochemical studies, left L4-L5 DRGs
were removed from the experimental (axotomized) and
control (sham) groups and post-fixed for 2-3 h in 4%
paraformaldehyde in 0.1 M phosphate buffer (PBS). The
fixed DRGs were then cryoprotected, cut on a cryostat at
10 μm thickness and mounted serially onto Superfrost/
plus microscope slides (Fisher Scientific) for staining.
After incubation in 0.3% Triton X-100 in PBS (PBST) for
2 h, the sections were blocked in 10% goat serum in PBST
for at least 4 h, followed by incubation with the primary
antibody overnight at 4°C. The following primary anti-
bodies were used: mouse monoclonal anti-Nnat (1:400;
Santa Cruz, USA), rabbit polyclonal anti-NF-200 (1:1000;
Sigma, USA), and rabbit polyclonal anti-Peripherin
(1:1000; Sigma, USA). After being washed three times
with PBST, the sections were incubated with secondary
antibodies at following concentrations: Alexa fluor 488
goat anti-mouse IgG (1:1000; Invitrogen, USA), and Alexa
fluor 594 goat anti-rabbit IgG (1:1000; Invitrogen, USA).
The sections were then washed and cover slipped using
ProLong™ Antifade mountant (Molecular Probes). The
sections were examined in a confocal fluorescence micro-
scope (Leica, TCS, SPII, Germany) and images captured
with a Nikon CoolPix 990 camera (Nikon, Tokyo, Japan).
Figures were assembled in Photoshop™.
All experimental data were presented as mean ± SEM
and carried out with one-way ANOVA with Tukey's post-
hoc analysis. A P value of < 0.05 was considered signifi-
cant.
Results
The sciatic nerve transection caused a significant
decrease in pain threshold detected 2 h after surgery, as
measured by the Randall and Selitto test. This phenome-
non was detected up to 7 days after surgery (Figure 1).
Sham-operated (control) animals did not present an
alteration in pain threshold compared to basal values
obtained immediately before the surgical procedure (Fig-
ure 1).Chen et al. Journal of Biomedical Science 2010, 17:41
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To investigate whether the increased expression of
Nnat found by our previous work with Affymetrix arrays
was consistent with increased protein expression, left L4-
L5 DRGs from 3 rats of control and experimental group
(post-axotomy day 1, 3, 5, and 7) were pooled for Western
blotting in triplicate (n = 9 for each group) to analyze
total Nnat (Nnat-α and Nnat-β) expression level. As
shown in Figure 2A, the expression level of total Nnat (a
molecular weight band of ~13 kDa) was progressively up-
regulated at 1, 3, 5, and 7 days post-axotomy compared to
the sham control rats. To quantify the band of each time
point, individual bands were normalized with the density
of GAPDH bands. As shown in Figure 2B, the immunore-
activity of total Nnat displayed significant up-regulation
compared with the sham control rats. The signal changes
of total Nnat were expressed as 2.8, 2.5, 3.5, and 4.2 times
at time points 1, 3, 5, and 7 days post-axotomy respec-
tively compared to control rats (P < 0.05, n = 9 for each
group).
In parallel studies, the expression of Nnat in DRG neu-
rons was examined by immunofluorescence staining
using frozen-cut tissues. Five to six sections of 10 μm
thickness (minimal separation of 90-100 μm) from left L4
or L5 DRG (n = 3 for each group) were evaluated and ana-
lyzed by one-way ANOVA with Tukey's post-hoc analy-
sis. Generally, peripheral sensory DRG neurons are
classified as small unmyelinated C-fiber or thinly myeli-
nated Aδ-fiber neurons that transmit signals about ther-
mal and noxious stimuli and large myelinated A-β fiber
neurons that transmit information about non-noxious
stimuli [5,6]. To examine the expression of Nnat in large
versus small DRG neurons, we co-localized Nnat by
immunofluorescence staining with peripherin, a marker
of small unmyelinated C-fiber and thinly myelinated A-δ
fiber neurons, and NF200, a marker of large myelinated
A-β fiber neurons [7,8]. Figure 3A and 3B show the dou-
ble labeling for Nnat and peripherin or NF200 in DRGs in
control sham rats, and figure 3C and 3D show double
labeling in post-axotomy day 7 rats. Neurons that were
double immunoreactive for both Nnat and peripherin
(small-sized DRG neurons) were increased in axotomized
rats compared to the control. However, those neurons
that were double immunoreactive for both Nnat and
NF200 (large-sized DRG neurons) were no significantly
changed (figure 3). Figure 4 shows statistical analysis of
immunohistochemistry of DRG neurons from control
and post-axotomy day 1, 3, 5, and 7 rats. In neurons that
stained positive for both Nnat and peripherin was 41.05 ±
1.3% in control rats and this percentage was significantly
higher in rats of post-axotomy day 1, 3, 5, and 7 (61.26 ±
2.9%, 63.82 ± 2.7%, 78.69 ± 5.6%, and 84.47 ± 2.2% respec-
tively) (P < 0.05, n = 3 for each group). In contrast, we did
not find any significant change between control and
experimental group in neurons with double stained-posi-
tive for Nnat and NF200. This result indicates that after
axotomy of sciatic nerve, the expression of Nnat is mainly
located at small-sized DRG neurons, such as small unmy-
elinated C-fiber and thinly myelinated A-δ fiber neurons.
Figure 1 Evaluation of hyperalgesia induced by rat sciatic nerve 
transection (neurectomy). Pain threshold was estimated in the rat 
paw pressure test applied before (time 0), and on days (d) 1, 3, 5, and 7 
after surgery in male S-D rats of approximately 8 weeks of age. Sham-
operated (Sham) rats were subjected to the same surgical procedure, 
without manipulation of the nerve. Time 0 corresponds to pain thresh-
old measure before surgery. Data represent mean values ± S.E.M. for 10 
rats per group. There was significant difference to the values obtained 
before surgery (time 0). There was also significant difference to the val-
ues of Sham group (* P < 0.05).
Figure 2 Total neuronatin protein contents (Nnat-α and Nnat-β) 
at different time points after axotomy of sciatic nerve in adult 
rats. (A) The total neuronatin protein contents from DRGs of control 
and post-axotomy day 1, 3, 5, and 7 were subjected to Western blot 
analysis. (B) The total neuronatin protein expression levels. Individual 
band was quantitated, and normalized with the density of its own 
GAPDH. Value are presented as mean ± S.E.M. (* P < 0.05 compared 
with control rats, n = 9 for each group).Chen et al. Journal of Biomedical Science 2010, 17:41
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Discussion
Neuronatin (Nnat) was initially identified as a gene selec-
tively expressed in neonatal brains, especially in the hind-
brain and pituitary gland, and is highly conserved in
species such as rat, mouse and human [2,9]. Due to the
abundant expression of Nnat mRNA during late fetal and
early postnatal periods of mammalian brain develop-
ment, and downregulation during adulthood and senes-
cence, it was suggested that Nnat may be involved in
neonatal neuronal cell differentiation during develop-
ment [1]. Although Nnat is mainly known to be expressed
in the central nervous system, particularly in the develop-
mental brain, it is also expressed in non-neuronal tissues
such as the pituitary glands, lungs, adrenal glands, uterus,
skeletal muscles, ovaries, adipose tissues, and pancreas
[10-14].
Nnat has two alternatively spliced forms: neuronatin-α
(Nnat-α) and neuronatin-β (Nnat-β). Both had the same
translation start site, open reading frame, stop and termi-
nation signals with Nnat-α encoding 81 aa and Nnat-β 54
aa. The only difference between the α and β forms of
Nnat was the presence in the α-form of an additional 81
nt sequence encoding 27 aa located in the middle of the
coding region and the absence of a small transmembrane
domain in β-form, which in normal children and adults is
present at only low levels [13,15,16]. Tentatively, based on
the cDNA sequences, it is suggested that Nnat-α has
three exons, the first containing 72 nt encoding 24 aa, the
second containing 81 nt encoding 27 aa, and the third
with 90 nt encoding 30 aa. As Nnat-β contains only the
first and third exons, it appears to be derived from the α-
form by splicing out of the middle exon. The shorter β-
form first appears in mid gestation (E11-14), a time when
the neural tube has closed and neuroepithelial prolifera-
tion and commitment to a neuronal or glial fate are tak-
ing place. On the other hand, α-form appears even earlier
in gestation (E7-10), and the abundance of the α-form
was also increased in mid-gestation. The two Nnat iso-
forms have distinct patterns of expression during devel-
opment suggesting that there is differential regulation
between the two isoforms and that there are possibly dif-
ferent roles played by the two isoforms during develop-
ment [2,17]. It appears that the splicing mechanism that
generates the β-form becomes active during neurogene-
sis. It may be speculated that the removal of the middle
exon may be important to function of this gene [2]. Nnat
has also been identified as an imprinting gene, which is
maternally imprinted and there is only expression of the
paternal allele mapping to mouse chromosome 2. And
during development, Nnat expression is regulated by epi-
genetic modifications [18-21]. By virtue of its expression
pattern during development, Nnat has been postulated to
participate in the maintenance of segment identity in the
mammalian hindbrain [9].
Figure 3 Immunohistochemistry of neuronatin, NF200 (marker 
for large myelinated A-β fiber neurons), and peripherin (marker 
for unmyelinated C-fiber and thinly myelinated A-δ fiber neu-
rons) in DRG neurons on post-axotomy day 7. Confocal image of 
DRG neurons immunostained with anti-neuronatin (red), anti-NF200 
(green), and anti-peripherin (green). The double immunoreactivity-
positive DRG neurons for neuronatin and peripherin (A) or neuronatin 
and NF200 (B) in control sham group, and neuronatin and peripherin 
(C) or neuronatin and NF200 (D) in post-axotomy day 7 group are illus-
trated. Note that the neurons that were double immunoreactive for 
Nnat and peripherin were increased in axotomized rats. Scale bar, 50 
μm.
Figure 4 Statistical analysis of immunohistochemistry of DRG 
neurons from control and post-axotomy day 1, 3, 5, and 7 rats. 
Five to six sections of 10 μm thickness (minimal separation of 90-100 
μm) from left L4 or L5 DRG were evaluated. Double immunofluores-
cence labeling using anti-Nnat, anti-peripherin (marker for unmyeli-
nated C-fiber and thinly myelinated A-δ fiber neurons) and anti-NF200 
(marker for large myelinated A-β fiber neurons) antibodies were used 
to differentiate subpopulation of DRG neurons. Note: The percentage 
counted for double-labeling was based on the following criteria: in 
Nnat stained-positive neurons, neurons also stained-positive for pe-
ripherin (peripherin(+)) or NF200 (NF200(+)). Value are presented as 
mean ± S.E.M. * Indicates significant difference between control and 
post-axotomy rats analyzed by one-way ANOVA with Tukey's post-hoc 
analysis (P < 0.05, n = 3 for each group).Chen et al. Journal of Biomedical Science 2010, 17:41
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Recent study conducted by Mzhavia et al. [22] showed
that Nnat, an imprinted gene with unknown vascular
functions, was up-regulated in both db/db and high-fat
diet-fed mouse aortas. Their immunohistochemical
staining revealed that Nnat was expressed on the vascular
endothelium. To investigate the function of Nnat, they
used recombinant adenovirus (Ad-Nnat) to overexpress
the Nnat gene in primary human aortic endothelial cells
(HAECs) and in the mouse aorta in vivo. Their results
showed that overexpression of Nnat in HAECs or in
mouse carotid artery would induce increased expression
of a panel of nuclear factor-kappaB (NF-κB)-regulated
genes, including inflammatory cytokines, chemokines,
a n d  c e l l  a d h e s i o n  m o l e c u l e s .  T h e y  s u g g e s t e d  t h a t  t h i s
effect of Nnat in both db/db and high-fat diet-fed mouse
aortas was mediated through phosphatidylinositol 3-
kinase and p38 mitogen-activated protein kinase-depen-
dent activation of NF-κB and might also reflect altera-
tions in the methylation status of endothelial cells.
NF-kappaB is a transcription factor which serves as a
transducer between extracellular signals and gene expres-
sion. It plays a pivotal role in cell regulation, such as pro-
liferation, immune cell activation, apoptosis, stress
responses, differentiation and oncogenic transformation
[23]. In most unstimulated cells, NF-kappaB is retained as
an inactive form in the cytoplasm by binding to members
of the inhibitory factor kappaB (IκB) family. Upon appro-
priate stimulation, IκB is phosphorylated and degraded,
allowing NF-kappaB to translocate to the nucleus where
it binds DNA and triggers the transcription of target
genes, such as proinflammatory cytokines, chemokines,
and cell adhesion molecules. NF-kappaB activation may
thus amplify the spinal cord and DRG proinflammatory
response, thereby further facilitating pain transmission
[23,24]. Recently several studies have shown that activa-
tion of NF-kappaB occurs in the DRG and spinal cord,
which are both involved in the transmission and process-
ing of nociceptive information leading to pathogenesis of
neuropathic pain [25,26]. Furthermore, Y ang et al. [27]
have demonstrated that activation of NF-kappaB in small
diameter sensory neurons of DRG is involved in the
growth-related oncogene (GRO/KC; CXCL1)-induced
enhancement of potassium currents in both nerve injury
and inflammatory pain models. In addition, Liu et al. [28]
have identified that spinal long-term potentiation of C-
fiber evoked field potentials can be induced by tumor
necrosis factor-α in neuropathic rats, which is also NF-
kappaB dependent process. Therefore, inhibition of NF-
kappaB pathway by different strategies has been used to
attenuate chronic pain states in different animal models
of neuropathic pain [29-31].
In comparison to our study, it was found that after axo-
tomy of sciatic nerve, there were many novel genes with
significant expression changes. Many were down-regu-
lated and others were up-regulated. Among them, Nnat
was the one which expression was significantly up-regu-
lated. It is striking that Nnat, an imprinting gene strongly
expressed mainly in neonatal developing brain, increased
its expression in adult rats DRGs after axotomy of sciatic
nerve. Although it is not clear why Nnat expression was
increased in DRG cells of axotomized rat, it is possible
that a peripheral nerve injury such as axotomy of sciatic
nerve, being one of the most used animal models of neu-
ropathic pain, is able to create a "micro-environment"
stress strong enough to trigger undergoing epigenetic
modifications in Nnat leading to unexpected increased
expression in adult DRG cells. In addition, based on the
Western blot results, the expression profile of total Nnat
(Nnat-α and Nnat-β) was significantly up-regulated. This
suggested that the increased expression of total Nnat was
induced by peripheral nerve injury. Furthermore, accord-
ing to the immunohistochemical results, it showed that
after the sciatic nerve was axotomized, the subcellular
localization of Nnat in DRG was confirmed by periph-
erin-positive neuronal cells, where the expression of Nnat
was also increased. This subpopulation of primary affer-
ent neurons demonstrated a low level of expression of
Nnat in the control (Sham group) and suggests that Nnat
is expressed mainly on unmyelinated C-fiber and thinly
myelinated A-δ fiber neurons. This finding is consistent
with the up-regulation of total Nnat protein. Nnat may
therefore contribute to neuropathic pain after peripheral
nerve injury, given that C-fiber and A-δ fiber are the prin-
cipal neurons for transmitting information about thermal
and noxious stimuli [5,6]. This finding was in accordance
with the mechanical paw-withdrawal test, which showed
that after the sciatic nerve was transected, the withdrawal
latency was decreased significantly, suggesting that the
increased noxious input from mechanical stimuli induces
hyperalgesia characteristic of neuropathic pain.
Therefore, the scenario we speculate here is that sciatic
nerve transection in adult rats might create a stressful
micro-environment strong enough to trigger epigenetic
modifications on the expression of Nnat, notably increas-
ing it to a significant degree in a selective subpopulation
of adult DRG neurons, specifically in sensory C and A-δ
fiber neurons. Then, Nnat activates NF-kappaB through
phosphatidylinositol 3-kinase and p38 mitogen-activated
protein kinase signal pathway. The activation of NF-kap-
paB might trigger a cascade of pathophysiological pro-
cesses to occur: 1) The expression of NF-kappaB-related
inflammatory mediators would be increased to exert
their inflammatory component in the model of neuro-
pathic pain; 2) Among the inflammatory mediators
expressed, tumor necrosis factor-alpha (TNF-α) has the
ability of persistent reactivation of NF-kappaB forming
an amplification loop [24], which might be the initial step
for activation of others immune cells in DRG and spinalChen et al. Journal of Biomedical Science 2010, 17:41
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cord causing persistent inflammatory reaction; 3) The
activation of NF-kappaB in small diameter sensory neu-
rons, such as C-fiber and A-δ fiber, might induce patho-
logical channel currents enhancement and/or long-term
potentiation that lead to a state of chronic pain. Hence,
the peripheral and central sensitization characterized in
neuropathic pain might be induced and maintained by
the possible processes mentioned above. However, since
Nnat is not necessarily the only cause for a specific phe-
notype of neuropathy, it is possible that other novel
imprinted genes may exist in regions not identified by
genetic studies that may contribute to the same or dis-
tinct phenotype of neuropathy. Therefore, further work is
necessary to confirm the speculation we proposed here.
Conclusions
Our data showed that axotomy of sciatic nerve in adult
rats induced an increased expression of Nnat in DRG
neurons, specifically in unmyelinated C-fiber and thinly
myelinated A-δ fiber neurons, the primary afferent neu-
rons involved in the transmission of noxious stimulus.
Using this as a model to demonstrate neuropathic pain,
we suggest that the expression of Nnat in the primary
sensory neurons correlates well with mechanical hyperal-
gesia observed in our animals. This is the first observa-
tional study characterizing Nnat as having a potential
functional role in neuropathic pain.
Additional material
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
KHC designed and performed the experiments, analyzed the data, and drafted
the manuscript. CHY co-designed and co-performed the experiments and par-
ticipated in the analysis of the experimental results. JTC participated in the dis-
cussion of the experimental results. CHW and WDS co-performed the
experiments. CRL conceived the study, coordinated the implementation of the
study and revised the final manuscript. All authors read and approved the final
manuscript.
Acknowledgements
This work was supported in part by grant No. 870641, 860231, and 860232 
from Chang Gung Memorial Hospital Research, Kaohsiung, Taiwan, and by 
grant No. 95-2745-B-182A-004, 96-2628-B-182A-005-MY3, and 98-2314-B-
182A-035-MY2 from the Taiwan National Science Council Research, Taipei, Tai-
wan.
Author Details
1Department of Anesthesiology, Chang Gung Memorial Hospital-Kaohsiung 
Medical Center, Chang Gung University College of Medicine, Kaohsiung, 
Taiwan, 2Department of Biological Sciences, National Sun Yat-Sen University, 
Kaohsiung, Taiwan and 3Department of Anesthesiology, National Taiwan 
University College of Medicine, Taipei, Taiwan
References
1. Joseph R, Dou D, Tsang W: Molecular cloning of a novel mRNA 
(neuronatin) that is highly expressed in neonatal mammalian brain.  
Biochemical and Biophysical Research Communications 1994, 
201:1227-1234.
2. Joseph R, Dou D, Tsang W: Neuronatin mRNA: alternatively spliced 
forms of a novel brain-specific mammalian developmental gene.  Brain 
research 1995, 690:92-98.
3. Wall PD, Waxman S, Basbaum AI: Ongoing activity in peripheral nerve: 
injury discharge.  Experimental neurology 1974, 45:576.
4. Randall LO, Selitto JJ: A method for measurement of analgesic activity 
on inflamed tissue.  Archives internationales de pharmacodynamie et de 
therapie 1957, 111:409.
5. Baba H, Doubell TP, Woolf CJ: Peripheral inflammation facilitates Aβ 
fiber-mediated synaptic input to the substantia gelatinosa of the adult 
rat spinal cord.  Journal of Neuroscience 1999, 19:859-867.
6. Lawson SN: Phenotype and function of somatic primary afferent 
nociceptive neurones with C-, A [delta]-or A [alpha]/[beta]-fibres.  
Experimental physiology 2002, 87:239-244.
7. Ma QP: Expression of capsaicin receptor (VR1) by myelinated primary 
afferent neurons in rats.  Neuroscience letters 2002, 319:87-90.
8. Amaya F, Decosterd I, Samad TA, Plumpton C, Tate S, Mannion RJ, 
Costigan M, Woolf CJ: Diversity of expression of the sensory neuron-
specific TTX-resistant voltage-gated sodium ion channels SNS and 
SNS2.  Molecular and Cellular Neuroscience 2000, 15:331-342.
9. Wijnholds J, Chowdhury K, Wehr R, Gruss P: Segment-specific expression 
of the neuronatin gene during early hindbrain development.  
Developmental Biology 1995, 171:73-84.
10. Arava Y, Adamsky K, Ezerzer C, Ablamunits V, Walker MD: Specific gene 
expression in pancreatic beta-cells: cloning and characterization of 
differentially expressed genes.  Diabetes 1999, 48:552-556.
11. Niwa H, Harrison LC, DeAizpurua HJ, Cram DS: Identification of 
Pancreatic β Cell-Related Genes by Representational Difference 
Analysis 1.  Endocrinology 1997, 138:1419-1426.
12. Suh YH, Kim WH, Moon C, Hong YH, Eun SY, Lim JH, Choi JS, Song J, Jung 
MH: Ectopic expression of Neuronatin potentiates adipogenesis 
through enhanced phosphorylation of cAMP-response element-
binding protein in 3T3-L1 cells.  Biochemical and Biophysical Research 
Communications 2005, 337:481-489.
13. Usui H, Morii K, Tanaka R, Tamura T, Washiyama K, Ichikawa T, Kumanishi T: 
cDNA cloning and mRNA expression analysis of the human 
neuronatin.  Journal of Molecular Neuroscience 1997, 9:55-60.
14. Okubo C, Minami Y, Tanaka R, Uchihara T, Anami Y, Furuya S, Morishita Y, 
Iijima T, Noguchi M: Analysis of differentially expressed genes in 
neuroendocrine carcinomas of the lung.  Journal of Thoracic Oncology 
2006, 1:780.
15. Evans HK, Wylie AA, Murphy SK, Jirtle RL: The neuronatin gene resides in 
a "micro-imprinted" domain on human chromosome 20q11. 2.  
Genomics 2001, 77:99-104.
16. Dou D, Joseph R: Cloning of human neuronatin gene and its 
localization to chromosome-20q11. 2-12: the deduced protein is a 
novel 'proteolipid'.  Brain research 1996, 723:8-22.
17. Siu I: Coexpression of neuronatin splice forms promotes 
medulloblastoma growth.  Neuro-Oncology 2008, 10:716.
18. Kagitani F, Kuroiwa Y, Wakana S, Shiroishi T, Miyoshi N, Kobayashi S, 
Nishida M, Kohda T, Kaneko-Ishino T, Ishino F: Peg5/Neuronatin is an 
imprinted gene located on sub-distal chromosome 2 in the mouse.  
Nucleic acids research 1997, 25:3428.
Additional file 1 Intensity of average values of neuronatin (Nnat) in 
naïve and axotomy groups. Changes of mean intensity from triplicate 
naïve (day 0) against triplicate 3, 7, 21, and 40 day axotomy show signifi-
cantly higher level of intensity of Nnat (accession number: U08290) in post-
axotomy groups compared to the naïve group. The mean intensity ± S.D. of 
Nnat in each group were: naïve = 1881 ± 88, post-axotomy day 3 = 4167 ± 
712, post-axotomy day 7 = 3918 ± 946, post-axotomy day 21 = 3570 ± 723, 
and post-axotomy day 40 = 3078 ± 477. The mean intensity fold changes of 
Nnat were expressed as 2.2, 2.0, 1.8, and 1.6 times at time points 3, 7, 21, and 
40 days post-axotomy respectively compared to naïve group. * Indicates 
significant difference between naïve and post-axotomy group analyzed by 
one-way ANOVA with Tukey's post-hoc analysis (P < 0.05, n = 15 for each 
group).
Received: 13 January 2010 Accepted: 28 May 2010 
Published: 28 May 2010
This article is available from: http://www.jbiomedsci.com/content/17/1/41 © 2010 Chen et al; licensee BioMed Central Ltd.  This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Journal of Biomedical Science 2010, 17:41Chen et al. Journal of Biomedical Science 2010, 17:41
http://www.jbiomedsci.com/content/17/1/41
Page 7 of 7
19. Kikyo N, Williamson CM, John RM, Barton SC, Beechey CV, Ball ST, 
Cattanach BM, Surani MA, Peters J: Genetic and Functional Analysis 
ofneuronatinin Mice with Maternal or Paternal Duplication of Distal 
Chr 2.  Developmental Biology 1997, 190:66-77.
20. John RM, Aparicio S, Ainscough JFX, Arney KL, Khosla S, Hawker K, Hilton 
KJ, Barton SC, Surani MA: Imprinted expression of neuronatin from 
modified BAC transgenes reveals regulation by distinct and distant 
enhancers.  Developmental Biology 2001, 236:387-399.
21. Williamson CM, Beechey CV, Ball ST, Dutton ER, Cattanach BM, Tease C, 
Ishino F, Peters J: Localisation of the imprinted gene neuronatin, Nnat, 
confirms and refines the location of a second imprinting region on 
mouse chromosome 2.  Cytogenet Cell Genet 1998, 81:73-78.
22. Mzhavia N, Yu S, Ikeda S, Chu TT, Goldberg I, Dansky HM: Neuronatin: a 
new inflammation gene expressed on the aortic endothelium of 
diabetic mice.  Diabetes 2008, 57:2774.
23. O'Neill LA, Kaltschmidt C: NF-kB: a crucial transcription factor for glial 
and neuronal cell function.  Trends in neurosciences 1997, 20:252-258.
24. Barnes PJ, Karin M: Nuclear factor-{kappa} B--a pivotal transcription 
factor in chronic inflammatory diseases.  The New England journal of 
medicine 1997, 336:1066.
25. Ma W, Bisby MA: Increased activation of nuclear factor kappa B in rat 
lumbar dorsal root ganglion neurons following partial sciatic nerve 
injuries.  Brain research 1998, 797:243-254.
26. Lee KM, Kang BS, Lee HL, Son SJ, Hwang SH, Kim DS, Park JS, Cho HJ: 
Spinal NF-kB activation induces COX-2 upregulation and contributes to 
inflammatory pain hypersensitivity.  European Journal of Neuroscience 
2004, 19:3375-3381.
27. Yang RH, Strong JA, Zhang JM: NF-κB mediated enhancement of 
potassium currents by the chemokine CXCL 1/growth related 
oncogene in small diameter rat sensory neurons.  Molecular Pain 2009, 
5:26.
28. Liu YL, Zhou LJ, Hu NW, Xu JT, Wu CY, Zhang T, Li YY, Liu XG: Tumor 
necrosis factor-[alpha] induces long-term potentiation of C-fiber 
evoked field potentials in spinal dorsal horn in rats with nerve injury: 
The role of NF-kappa B, JNK and p38 MAPK.  Neuropharmacology 2007, 
52:708-715.
29. Inoue G, Ochiai N, Ohtori S, Nakagawa K, Gemba T, Doya H, Ito T, Koshi T, 
Moriya H, Takahashi K: Injection of nuclear factor-kappa B decoy into 
the sciatic nerve suppresses mechanical allodynia and thermal 
hyperalgesia in a rat inflammatory pain model.  Spine 2006, 31:2904.
30. Sun T, Song WG, Fu ZJ, Liu ZH, Liu YM, Yao SL: Alleviation of neuropathic 
pain by intrathecal injection of antisense oligonucleotides to p65 
subunit of NF-{kappa} B.  British Journal of Anaesthesia 2006, 97:553.
31. Meunier A, Latremoliere A, Dominguez E, Mauborgne A, Philippe S, 
Hamon M, Mallet J, Benoliel JJ, Pohl M: Lentiviral-mediated Targeted NF-
κB Blockade in Dorsal Spinal Cord Glia Attenuates Sciatic Nerve Injury-
induced Neuropathic Pain in the Rat.  Molecular Therapy 2007, 
15:687-697.
doi: 10.1186/1423-0127-17-41
Cite this article as: Chen et al., Altered neuronatin expression in the rat dor-
sal root ganglion after sciatic nerve transection Journal of Biomedical Science 
2010, 17:41